Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (aUC): Long-term outcomes from the JAVELIN Bladder 100 trial in patients (pts) with high body mass index (BMI)

被引：2

作者：

Aragon-Ching, Jeanny B. ^{[1
]}

Petrylak, Daniel P. ^{[2
]}

Sridhar, Srikala S. ^{[3
]}

Gupta, Shilpa ^{[4
]}

Grivas, Petros ^{[5
,6
]}

Powles, Thomas ^{[7
]}

Gurney, Howard ^{[8
,9
]}

Jacob, Natalia ^{[10
]}

Tyroller, Karin ^{[11
]}

Guenther, Silke ^{[10
]}

Bellmunt, Joaquim ^{[12
]}

机构：

[1] Inova Schar Canc Inst, Fairfax, VA USA

[2] Yale Canc Ctr, New Haven, CT USA

[3] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada

[4] Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA

[5] Univ Washington, Div Hematol & Oncol, Seattle, WA USA

[6] Fred Hutchinson Canc Ctr, Seattle, WA USA

[7] Queen Mary Univ London, Barts Canc Inst, Canc Res UK Expt Canc Med Ctr, London, England

[8] Macquarie Univ, Fac Med Hlth & Human Sci, Sydney, NSW, Australia

[9] Westmead Hosp, Crown Princess Mary Canc Ctr, Macquarie Pk, Australia

[10] Merck KGaA, Healthcare Business, Darmstadt, Germany

[11] EMD Serono, Billerica, MA USA

[12] Dana Farber Canc Inst, Boston, MA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期

关键词：

D O I：

10.1200/JCO.2024.42.4_suppl.600

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：600 / 600

页数：1

共 50 条

[21] Avelumab first-line (1L) maintenance for advanced urothelial carcinoma (UC): Long-term follow-up from the JAVELIN Bladder 100 trial in subgroups defined by 1L chemotherapy regimen and analysis of overall survival (OS) from start of 1L chemotherapy.
Sridhar, Srikala S.
Powles, Thomas
Gupta, Shilpa
Climent, Miguel Angel
Aragon-Ching, Jeanny B.
Sternberg, Cora N.
Cislo, Paul
Costa, Nuno
Di Pietro, Alessandra
Bellmunt, Joaquim
Grivas, Petros
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
[22] Long-term outcomes in patients with advanced urothelial carcinoma (UC) who received avelumab first-line (1 L) maintenance with or without second-line (2 L) treatment: Exploratory analyses from JAVELIN Bladder 100
Bellmunt, Joaquim
Powles, Thomas
Duran, Miguel A. Climent
Sridhar, Srikala S.
Gurney, Howard
Pook, David W.
Costa, Nuno
Di Pietro, Alessandra
Huang, Bo
Gupta, Shilpa
Grivas, Petros
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 137 - 138
[23] AVELUMAB FIRST-LINE MAINTENANCE FOR ADVANCED UROTHELIAL CARCINOMA: LONG-TERM OUTCOMES FROM JAVELIN BLADDER 100 IN SUBGROUPS DEFINED BY FIRST-LINE CHEMOTHERAPY REGIMEN AND ANALYSIS OF OVERALL SURVIVAL FROM START OF FIRST-LINE CHEMOTHERAPY
Sridhar, Srikala S.
Powles, Thomas
Gupta, Shilpa
Climent Duran, Miguel A.
Aragon-Ching, Jeanny B.
Sternberg, Cora N.
Cislo, Paul
Costa, Nuno
Salvo, Porto
di Pietro, Alessandra
Bellmunt, Joaquim
Grivas, Petros
JOURNAL OF UROLOGY, 2024, 211 (05): : E806 - E807
[24] Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Analysis from JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before Maintenance
Sridhar, Srikala S.
Powles, Thomas
Duran, Miguel A. Climent
Park, Se Hoon
Massari, Francesco
Thiery-Vuillemin, Antoine
Valderrama, Begona P.
Ullen, Anders
Tsuchiya, Norihiko
Aragon-Ching, Jeanny B.
Gupta, Shilpa
Petrylak, Daniel P.
Bellmunt, Joaquim
Wang, Jing
Laliberte, Robert J.
di Pietro, Alessandra
Costa, Nuno
Grivas, Petros
Sternberg, Cora N.
Loriot, Yohann
EUROPEAN UROLOGY, 2024, 85 (02) : 154 - 163
[25] Full analysis from AVENANCE: A real-world study of avelumab first-line (1L) maintenance treatment in patients (pts) with advanced urothelial carcinoma (aUC).
Barthelemy, Philippe
Loriot, Yohann
Voog, Eric
Eymard, Jean Christophe
Ravaud, Alain
Flechon, Aude
Jaillon, Christine Abraham
Chasseray, Matthieu
Lorgis, Veronique
Hilgers, Werner
Gobert, AurElien
Le Moulec, Sylvestre
Simon, Camille
Nicolas, Emanuel
Escande, Anne
Pouessel, Damien
Josse, Constant
Solbes, Marie-Noelle
Lambert, Prisca
Thibault, Constance
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
[26] The JAVELIN Bladder Medley trial: avelumab-based combinations as first-line maintenance in advanced urothelial carcinoma
Hoffman-Censits, Jean
Grivas, Petros
Powles, Thomas
Hawley, Jessica
Tyroller, Karin
Seeberger, Sonja
Guenther, Silke
Jacob, Natalia
Mehr, Keyvan Tadjalli
Hahn, Noah M.
FUTURE ONCOLOGY, 2024, 20 (04) : 179 - 190
[27] Avelumab first-line maintenance for advanced urothelial carcinoma: analysis of clinical and genomic subgroups from the phase 3 JAVELIN Bladder 100 trial
Lumba, Sumit
Powles, Thomas
Petrylak, Daniel P.
Park, Se Hoon
Sridhar, Srikala S.
Caserta, Claudia
Thiery-Vuillemin, Antoine
Lee, Hyo Jin
Bellmunt, Joaquim
Yamamoto, Yoshiaki
Aragon-Ching, Jeanny B.
Huang, Bo
Ching, Keith A.
Davis, Craig
di Pietro, Alessandra
Loriot, Yohann
Grivas, Petros
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 44 - 45
[28] Avelumab first-line maintenance for advanced urothelial carcinoma: analysis of clinical and genomic subgroups from the phase 3 JAVELIN Bladder 100 trial
Lumba, Sumit
Powles, Thomas
Petrylak, Daniel P.
Park, Se Hoon
Sridhar, Srikala S.
Caserta, Claudia
Thiery-Vuillemin, Antoine
Lee, Hyo Jin
Bellmunt, Joaquim
Yamamoto, Yoshiaki
Aragon-Ching, Jeanny B.
Huang, Bo
Ching, Keith A.
Davis, Craig
di Pietro, Alessandra
Loriot, Yohann
Grivas, Petros
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 126 - 127
[29] Avelumab First-Line Maintenance for Advanced Urothelial Carcinoma: Results From the JAVELIN Bladder 100 Trial After ≥2 Years of Follow-Up
Powles, Thomas
Park, Se Hoon
Caserta, Claudia
Valderrama, Begona P.
Gurney, Howard
Ullen, Anders
Loriot, Yohann
Sridhar, Srikala S. S.
Sternberg, Cora N. N.
Bellmunt, Joaquim
Aragon-Ching, Jeanny B. B.
Wang, Jing
Huang, Bo
Laliberte, Robert J. J.
di Pietro, Alessandra
Grivas, Petros
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (19) : 3486 - +
[30] Avelumab First-line Maintenance Therapy for Advanced Urothelial Carcinoma: Comprehensive Clinical Subgroup Analyses from the JAVELIN Bladder 100 Phase 3 Trial
Grivas, Petros
Park, Se Hoon
Voog, Eric
Caserta, Claudia
Gurney, Howard
Bellmunt, Joaquim
Kalofonos, Haralabos
Ullen, Anders
Loriot, Yohann
Sridhar, Srikala S.
Yamamoto, Yoshiaki
Petrylak, Daniel P.
Sternberg, Cora N.
Gupta, Shilpa
Huang, Bo
Costa, Nuno
Laliberte, Robert J.
di Pietro, Alessandra
Valderrama, Begona P.
Powles, Thomas
EUROPEAN UROLOGY, 2023, 84 (01) : 95 - 108

← 1 2 3 4 5 →